TEVA
Stock Details
TEVA is Teva Pharmaceutical Industries Limited's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 9.70$. Average daily volumn in 3 months 9.34M. Market cap 9.92B
Stock symbol : TEVA. Exchange : NYSE. Currency : USD Lastest price : 8.85$. Total volume : 5.36M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Teva Pharmaceutical Industries Limited (TEVA)
Last Price
8.85$Change
0.03Volume
5.36M
| Previous Close | 8.82 |
| Open | 8.88 |
| Day Range | 8.80-8.90 |
| Bid | 8.85 x 4k |
| Ask | 8.93 x 900 |
| Volume | 5.36M |
| Average Volume | 9.34M |
| Market Cap | 9.92B |
| Beta | 1.22 |
| 52 Week Range | 6.78-11.45 |
| Trailing P/E | N/A |
| Foward P/E | 3.51 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | 2017-11-27 |
Financial Details
Organization
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells activ... e pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Market Cap:
9.92BRevenue:
14.93BTotal Assets:
44.01BTotal Cash:
2.8B
News about "Teva Pharmaceutical Industries Limited"
Teva Pharmaceutical Industries Ltd
Source from : Reuters - 2 days ago
2022 Businesscategory U.S. FDA warns of ADHD drug Adderall shortage on Teva manufacturing delays, article with image October 12, 2022 Businesscategory European Commission suspects pharma group ...See details»
With 61% ownership of the shares, Teva Pharmaceutical Industries Limited (NYSE:TEVA) is heavily dominated by institutional owners
Source from : YAHOO!Finance - 6 days ago
Key Insights Given the large stake in the stock by institutions, Teva Pharmaceutical Industries' stock price might ...See details»
Teva Pharmaceutical Industries Limited (TEVA) Stock: A Review of the Recent Movement
Source from : newsheater - 1 days ago
The stock of Teva Pharmaceutical Industries Limited (TEVA) has gone up by 3.40% for the week, with a -12.50% drop in the past month and a -3.92% drop in the past quarter. The volatility ratio for the ...See details»
Teva Pharmaceutical Industries Limited (TEVA) Sits And Waits For Direction At $8.82 Price
Source from : stocksregister - 1 days ago
Teva Pharmaceutical Industries Limited (NYSE:TEVA) concluded the trading at $8.82 on Thursday, March 30 with a fall of -0.23% from its closing price on previous day. Taking a look at stock we notice ...See details»
Are Teva Pharmaceutical Industries Limited (NYSE: TEVA) Analysts Predicting A Spike?
Source from : stocksregister - 7 days ago
Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares, rose in value on Friday, 03/24/23, with the stock price down by -1.06% to the previous day’s close as strong demand from buyers drove the ...See details»
Teva Pharmaceutical
Source from : Forbes - 29 days ago
Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and ...See details»
Teva Pharmaceutical Industries Limited (TEVA) Stock Sees a-2.29 Decrease
Source from : newsheater - 8 days ago
The stock of Teva Pharmaceutical Industries Limited (TEVA) has gone up by 0.35% for the week, with a -14.36% drop in the past month and a -1.84% drop in the past quarter. The volatility ratio for the ...See details»
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Source from : Nasdaq - 10 years ago
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...See details»
Teva Pharmaceutical Industries Limited: Maintaining HOLD ahead of 4Q results
Source from : Yahoo Finance - 2 month ago
At Argus Research, Jasper covers the Growth Pharmaceutical ... Prior to joining Argus, Jasper worked in a variety of industries, ranging from investment tradeshow management to musical instrument ...See details»
Teva Announces Early Tender Results of its Debt Tender Offer, Increases to Tender Caps and Election of Early Settlement
Source from : Stockhouse - 19 days ago
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the early tender results in connection with its previously announced tender offers (the “Offers ...See details»
Teva Pharmaceutical Industries Limited (TEVA)
Source from : Yahoo Finance - 2 years ago
New product launches provide some respite to AMPH, RDY and TEVA. TEL AVIV, Israel, March 01, 2023--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today that it ...See details»
Teva Pharmaceutical Industries Ltd. ADR
Source from : Wall Street Journal - 7 days ago
Vergis Independent Director Dentsply Sirona, Inc., Teva Pharmaceutical Industries Ltd., Dentsply Sirona France SAS, SGS SA, National Association of Corporate Directors, Church & Dwight Co., Inc ...See details»
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Source from : Nasdaq - 5 years ago
The report is limited to equity securities, including common and equivalents, convertible preferred and convertible bonds. The report does not include fixed income, real estate, or cash equivalents.See details»
Teva Pharmaceutical Industries Limited (TEVA)
Source from : Yahoo Finance - 2 years ago
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...See details»